Maria Koehler - Dec 11, 2023 Form 4 Insider Report for Repare Therapeutics Inc. (RPTX)

Role
EVP, Chief Medical Officer
Signature
/s/ Steve Forte, Attorney-in-Fact
Stock symbol
RPTX
Transactions as of
Dec 11, 2023
Transactions value $
$98,755
Form type
4
Date filed
12/12/2023, 04:19 PM
Previous filing
Jun 13, 2023
Next filing
Mar 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPTX Common Shares Options Exercise $41.6K +20.2K +11.47% $2.06 196K Dec 11, 2023 Direct
transaction RPTX Common Shares Options Exercise $57.1K +23.6K +12.01% $2.43 220K Dec 11, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RPTX Employee Stock Option (right to buy) Options Exercise $0 -20.2K -45.45% $0.00 24.2K Dec 11, 2023 Common Shares 20.2K $2.06 Direct F1
transaction RPTX Employee Stock Option (right to buy) Options Exercise $0 -23.6K -21.17% $0.00 87.7K Dec 11, 2023 Common Shares 23.6K $2.43 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested and exercisable.
F2 Twenty-five percent (25%) of the shares subject to the option vested on December 16, 2020, and one thirty-ninth (1/39th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.